ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
124.61
-3.39 (-2.65%)
Jul 28, 2026, 12:12 PM EDT - Market open
ABIVAX Société Anonyme Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 477.42 | 516.69 | 144.22 | 251.94 | 26.95 | 60.7 |
Cash & Short-Term Investments | 477.42 | 516.69 | 144.22 | 251.94 | 26.95 | 60.7 |
Cash Growth | 360.94% | 258.26% | -42.76% | 834.85% | -55.60% | 107.16% |
Other Receivables | 22.03 | 21.42 | 7.55 | 9.19 | - | - |
Total Trade Receivables | 22.03 | 21.42 | 7.55 | 9.19 | - | - |
Other Current Assets | 13.77 | 13.14 | 18.9 | 24.85 | 9.23 | 14.78 |
Total Current Assets | 513.22 | 551.24 | 170.67 | 285.97 | 36.18 | 75.49 |
Net Property, Plant & Equipment | 1.78 | 2.09 | 2.67 | 0.88 | 1.59 | 0.31 |
Other Intangible Assets | 6.61 | 6.61 | 6.61 | 6.6 | 6.61 | 0.09 |
Goodwill | 18.42 | 18.42 | 18.42 | 18.42 | 18.42 | 32.01 |
Other Long-Term Assets | 7.12 | 5.98 | 6.87 | 15.19 | 12.75 | 1.34 |
Total Assets | 547.14 | 584.34 | 205.23 | 327.06 | 75.54 | 109.23 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 29.51 | 37.55 | 43.82 | 47.22 | 15.48 | 18.56 |
Accrued Expenses | 13.49 | 7.14 | 4.71 | 6.07 | 2.3 | 2.2 |
Current Portion of Long-Term Debt | 1.1 | 1.3 | 43.77 | 31.26 | 30.03 | 10.23 |
Unearned Revenue | - | - | - | 0.05 | 0.13 | 0.16 |
Other Current Liabilities | 18.13 | 17.03 | 1.7 | 6.09 | 3.52 | 1.11 |
Total Current Liabilities | 62.23 | 63.02 | 94 | 90.7 | 51.46 | 32.27 |
Long-Term Debt | 0.35 | 0.55 | 52.43 | 24.21 | 9.13 | 34.65 |
Other Long-Term Liabilities | 39.48 | 65.56 | 18.22 | 16.15 | 7.77 | 16.38 |
Total Long-Term Liabilities | 55.32 | 66.11 | 70.65 | 40.36 | 16.89 | 51.03 |
Total Liabilities | 117.55 | 129.14 | 164.64 | 131.05 | 68.36 | 83.3 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.79 | 0.79 | 0.63 | 0.63 | 0.22 | 0.17 |
Additional Paid-in Capital | 1,191 | 1,191 | 478.91 | 478.22 | 150.48 | 107.58 |
Accumulated Other Comprehensive Income | 2.03 | 2.31 | -0.08 | 0.11 | - | - |
Retained Earnings | -764.31 | -738.48 | -438.88 | -282.95 | -143.51 | -81.81 |
Shareholders' Equity | 429.59 | 455.21 | 40.58 | 196.01 | 7.19 | 25.93 |
Total Liabilities & Equity | 547.14 | 584.34 | 205.23 | 327.06 | 75.54 | 109.23 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1.45 | 1.86 | 96.2 | 55.47 | 39.16 | 44.88 |
Net Cash (Debt) | 475.98 | 514.83 | 48.03 | 196.48 | -12.21 | 15.82 |
Net Cash Growth | 4219.20% | 971.98% | -75.56% | - | - | - |
Net Cash Per Share | 6.49 | 7.41 | 0.76 | 4.56 | -0.64 | 1.02 |
Book Value | 429.59 | 455.21 | 40.58 | 196.01 | 7.19 | 25.93 |
Book Value Per Share | 5.85 | 6.55 | 0.64 | 4.55 | 0.38 | 1.68 |
Tangible Book Value | 404.57 | 430.18 | 15.56 | 170.99 | -17.84 | -6.16 |
Tangible Book Value Per Share | 5.51 | 6.19 | 0.25 | 3.97 | -0.93 | -0.40 |